Home About Our Services Experience Publications News & Events Contact Us Downloads
OUR SERVICES

Health Economics

Patient-Reported Outcomes

Regulatory and Health Outcomes Strategy

Market Access

Health Preference Assessment

Pharmacoepidemiology and Risk Management

Drug Safety and Pharmacovigilance

Biometrics
> Statistical Consulting
> Clinical Trial Data Analysis
> Health-Related Quality-of-Life Data Analysis
> Health Care Resource Utilization Data Analysis
> Registry and Survey Data Analysis
> Exploratory Data Analysis
> Meta-analyses, Including Indirect and Mixed Treatment Comparisons
> Statistical Programming
> Data Management

Clinical and Medical Services

 

RTI-HS HomeOur ServicesBiometrics › Health Care Resource Utilization Data Analysis

Health Care Resource Utilization Data Analysis

Health care resource utilization endpoints in phase 2/3 trials can indicate additional benefits to patients and provide supplementary evidence for registration. For example, reduced physician visits or less time in hospital can translate into large economic advantages over existing treatments. Health care resource use data that is collected during a clinical trial is often simply summarized in the clinical study report (CSR) and may be overlooked. Our team of statisticians and health economists help determine the costs and benefits of new treatments by applying unit costing to clinical trial data.

Our Expertise


 
CONTACT US

 
Neil Roskell, MSc
Director of Biostatistics, UK
Beth H Sherrill, MS
Global Head, Biometrics

For a full list of scientific staff bios, click here.

US: +1.800.262.3011
Spain: +34.93.241.7766
UK: +44(0)161.232.3400

 
 

Home | About | Our Services | Experience | Publications | News & Events | Contact Us | Downloads
©2008 RTI Health Solutions. All Rights Reserved.